Stefano Fiorucci Selected Research

NO-mesalamine

5/2005

Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Fiorucci Research Topics

Disease

47	Inflammation (Inflammations) 10/2022 - 01/2002
25	Colitis 01/2022 - 01/2002
15	Cholestasis 01/2020 - 08/2002
13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 11/2004
10	Insulin Resistance 10/2019 - 07/2007
9	Fatty Liver 01/2022 - 04/2010
9	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 12/2003
8	Neoplasms (Cancer) 01/2021 - 03/2004
8	Fibrosis (Cirrhosis) 06/2020 - 02/2004
8	Obesity 01/2019 - 03/2006
7	Liver Diseases (Liver Disease) 10/2021 - 02/2002
6	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2009
6	Pruritus (Itching) 10/2021 - 12/2014
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2012
6	Portal Hypertension 01/2016 - 12/2003
5	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 05/2009
5	Dyslipidemias (Dyslipidemia) 02/2014 - 04/2010
5	Atherosclerosis 05/2013 - 01/2010
5	Pain (Aches) 01/2013 - 01/2006
4	Crohn Disease (Crohn's Disease) 01/2022 - 11/2009
4	Disease Progression 01/2020 - 05/2005
4	Hepatitis 01/2020 - 11/2009
4	Body Weight (Weight, Body) 10/2019 - 09/2004
4	Hemorrhage 01/2013 - 01/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2009
3	Dysbiosis 01/2021 - 10/2019
3	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 09/2004
3	Weight Loss (Weight Reduction) 01/2019 - 11/2004
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 07/2007
3	Rheumatoid Arthritis 12/2013 - 12/2004
3	Arthritis (Polyarthritis) 12/2013 - 12/2004
3	Necrosis 01/2012 - 02/2002
3	Glycosuria 03/2010 - 04/2004
3	Edema (Dropsy) 01/2007 - 05/2002
2	Vascular System Injuries 01/2022 - 10/2010
2	Alcoholic Fatty Liver 01/2019 - 07/2007

Drug/Important Bio-Agent (IBA)

32	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 05/2005
29	LigandsIBA 10/2022 - 11/2004
15	Messenger RNA (mRNA)IBA 01/2022 - 01/2002
12	LipidsIBA 01/2022 - 07/2006
11	CholesterolIBA 01/2022 - 02/2009
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2004
9	obeticholic acidIBA 01/2020 - 08/2002
9	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2013 - 11/2004
8	CytokinesIBA 02/2019 - 05/2003
7	Sulfonic AcidsIBA 12/2017 - 01/2002
6	CollagenIBA 01/2018 - 12/2002
5	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2002
5	Interleukin-10 (Interleukin 10)IBA 06/2020 - 11/2002
5	Interleukin-6 (Interleukin 6)IBA 06/2020 - 12/2004
5	AcidsIBA 02/2019 - 10/2006
5	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018 - 10/2005
5	sym-trinitrobenzeneIBA 12/2017 - 01/2002
5	Pharmaceutical PreparationsIBA 06/2014 - 01/2004
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2013 - 05/2002
5	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2006 - 09/2005
4	GTP-Binding Proteins (G-Protein)IBA 01/2022 - 01/2019
4	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 02/2002
4	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2019 - 12/2003
4	Insulin (Novolin)FDA Link 01/2019 - 03/2006
4	Triglycerides (Triacylglycerol)IBA 01/2017 - 02/2009
4	Ritonavir (Norvir)FDA Link 01/2014 - 10/2010
4	SteroidsIBA 01/2013 - 11/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009 - 01/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2007 - 11/2002
3	isothiocyanic acidIBA 01/2020 - 01/2015
3	Dextrans (Dextran)FDA Link 02/2019 - 11/2004
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2014
3	Alkaline PhosphataseIBA 01/2019 - 12/2014
3	Dextran SulfateIBA 12/2017 - 11/2009
3	6-ethyl-3,7-dihydroxycholan-24-olIBA 10/2017 - 01/2015
3	OxazoloneIBA 01/2017 - 09/2005
3	Maraviroc FDA Link 01/2016 - 05/2013
3	Cadherins (E-Cadherin)IBA 01/2016 - 01/2013
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 01/2012
3	Pregnane X ReceptorIBA 12/2013 - 05/2009
3	Chemokine CCL5IBA 12/2013 - 10/2011
3	ChemokinesIBA 12/2013 - 10/2011
3	Apolipoproteins E (ApoE)IBA 05/2013 - 10/2010
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2013 - 04/2004
3	Rifaximin (L 105)FDA Link 10/2011 - 01/2002
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2009 - 01/2004
3	sodium bisulfide (NaHS)IBA 10/2006 - 09/2005
3	Peptide Hydrolases (Proteases)FDA Link 07/2006 - 11/2004
3	InterleukinsIBA 09/2005 - 01/2002
3	2- methyl- 3- (2- ((4- nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid esterIBA 09/2004 - 12/2003
2	EnzymesIBA 10/2022 - 07/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2022
2	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2022 - 01/2020
2	oxidized low density lipoproteinIBA 10/2021 - 01/2019
2	pelargonidinIBA 01/2021 - 08/2019
2	EstersIBA 01/2021 - 10/2006
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 08/2019
2	FructoseIBA 10/2019 - 01/2017
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2019 - 11/2004
2	Chenodeoxycholic Acid (Chenix)FDA Link 01/2019 - 10/2010

Therapy/Procedure

14	Therapeutics 01/2021 - 05/2002
4	Ligation 01/2020 - 02/2004
2	Liver Transplantation 01/2020 - 04/2019